Skip to content

Screener

Eligibility screening

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Sponsored by Conjupro Biotherapeutics, Inc.Study detailsClinicalTrials.gov

5 US sites in FL, TX, VA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.